Reply
Sir, I am thankful to Dr. H.D. Chopra for his letter. He has raised the following important issues (l) Role of ECT in Schizoprenia (2) Prognosis of Schizophrenia in different populations and (3) Phenomenology of schizophrenia in different populations.
1) Role of ECT in schizophrenia is a controversial issue which is yet far from settled. Various workers have often made contradictory claims. Our findings are to be interpreted in this context, i.e. our observations and conclusions are restricted on to our study and should not be regarded as definitive or as the last word on the role of ECT in schizophrenia. We are aware that while some studies and reviews may corroborate our conclusions; others may contradict.
2) Many workers have observed and reported that schizophrenia has better prognosis in the developing countries as compared to developed countries. Moreover, schizophrenic patients in the developing countries improve with smaller dose of neuroleptics given for fewer days, less number of ECTs and require shorter hospitalization. (Which may be one ot the reasons for the lesser incidence of side effects like tardive dyskinesia after neuroleptics and forgetfulness after ECT). Strong support from family members and relatives (dependability and not dependency) and ready social acceptance may also be the reasons tor better prognosis in developing countries. In fact, WHO has undertaken a multicentre project to study the role of low dose vs high dose of neuroleptics in different populations. The results are awaited. In a similar WHO study undertaken for depression, it was concluded that while depressed patients in the developing countries had similar improvement with low or high dose (100 mg or 150 mg per day respectively) of tricyclic antidepressants, the incidence of side effects was higher with the high dose regimen.
3) It is also noted that catatonic and acute subtypes of schizophrenia are more common in developing countries; which have better prognosis than other subtypes;. 
RAVI ABHYANKAR

Mental Health Bill
Sir, Your editorial "Farewell to Mental Health Bill" (Journal 1985) makes a refreshing reading. I take this opportunity to draw our reader's attention to one more lacuna in the said bill, which seems not to have been discussed anywhere so far. While this bill dwells at length on involuntary admission procedures, it is entirely silent about out-patient treatment of uncooperative psychotics.
In a city like Bombay, electro-convulsive therapy is given far more often on an out-door than an in-door basis, both in public hospitals and in private practice. It also hardly needs to be emphasised that psychotropic medication at times needs to be administered without patient's knowledge in domiciliary treatment of psychoses.
With all these areas still left uncovered can we really hope to see "Indian Psychiatry" march into 21 st century freed from the shackles it has been doomed to carry on with since the by-gone era of "Lunacy and Insanity" ? I strongly support the stand taken by you in the editorial and take the liberty to add that any possible cases of alleged malpractices should be left to the Medical Council to decide about, judiciary coming into picture only in the exceptional circumstances !
Bombay
Carbamazepine and Electro Convulsive Threshold
The points raised by Sharuia et al, in their letter "Does Carbainazepine Alter the Electro-Convulsive Threshold" (Joumal,27 173-174:1985) are topical and interesting. 1 lowever, the inference ... "Carbamazepine may be interfering with seizure threshold and...therapeutic induction of seizures" seems clouded by the following :-The patient was getting lithium 1800 mg., Carbamazepine (CBZ) 800 mg. and I'henob.irbitone (PB) 60 mg./day. It is difficult, especially in an epileptic subject, to incriminate CBZ alone out of combination of these three drugs which interact with each other in a complex manner and influence seizure activity. Absctuc or scrum levels of PB and CBZ further limits the experimental design and the scope of extrapolation of the data. In addition, animal experiments indicate that CBZ suppresses kindling process by repetitive sub-threshold electrical stimulation of the limbic structures and propagation of kindled seizure discharge to other brain areas (Wada 1977) . On the whole, the evidence to date suggests that the site of action of CBZ is predominantly on the limbic structures rather than the midbrain reticular formation or thalamus.
In the light of these data, and in keeping with the pioneering works of Kobayashi and co-workers (1967) as quoted by Okuma (1983), we feel that... "Carbamazepine produces no significant change in seizure threshold". This conviction is further strengthened by our recent observation on two patients; while on CBZ alone (600-900 mg/day), both could be given ECT with usual voltage and duration as in those patients not on CBZ. The patients reported by the authors might have needed more than average duration and stimulus due to presence of I'B. It may well be that the A-B-A-B design the authors employed itself had been responsible for lesser requirement ot stimulus and its duration. The altered schedule of CBZ 400 mg. a.m. and afternoon on the day previous to ECT had probably led to a state of relative CBZ withdrawal on the next morning when ECT was given. This withdrawal accentuated further by PB, could have lowered the seizure threshold by producing an altered biological state in a predisposed subject; this was corrected in the next phase when the original t.i.d. schedule was resumed.
It is not quite understandable how... "combined GABA-ergic effect of CBZ and ECT" could be held for the observations reported by the authors.
